Multi-Color Flow Cytometry Solution for In Vivo CAR-T Phenotypic Profiling: Memory vs. Exhaustion

Online Inquiry

Background Service What We Can Offer Workflow Highlights FAQs Contact

Despite the clinical success of CAR-T therapy, distinguishing functional memory phenotypes from dysfunctional exhausted states within the tumor microenvironment remains a major challenge, limiting the accurate prediction of long-term antitumor responses. To address this, we present Multi-color Flow Cytometry for In vivo CAR-T Phenotypic Profiling: Memory vs. Exhaustion, a specialized analytical approach. Our service provides high-dimensional immunophenotyping of key surface and intracellular markers on CAR-T cells directly from in vivo samples. By simultaneously resolving memory- and exhaustion-associated signatures, we deliver precise, quantitative profiling that empowers you to optimize therapeutic efficacy and assess persistence potential.

Introduction

CAR-T cells exhibit diverse phenotypic states that fundamentally determine their functional fate and therapeutic efficacy. Among these, memory CAR-T cells are characterized by high proliferative capacity and long-term persistence, whereas exhausted CAR-T cells display progressive loss of effector function and sustained expression of inhibitory receptors. Accurately distinguishing memory from exhaustion phenotypes is therefore critical for predicting antitumor responses, optimizing CAR design, and guiding combination strategies to improve clinical outcomes.

Fig.1 The immunological phenotype and defining characteristics of T cell subpopulations crucial for achieving efficacy in CAR-T cell therapy. (OA Literature) Fig.1 The relevant phenotypic and biological features of distinct T cell subsets that contribute to the success of CAR-T cell therapy.¹

Our Service

Our Multi-color Flow Cytometry service enables simultaneous in vivo profiling of memory and exhaustion markers on CAR-T cells. By resolving key phenotypic signatures, it distinguishes functional from dysfunctional states, providing precise immunophenotyping. This approach supports optimized therapeutic assessment, enhances prediction of antitumor persistence, and empowers preclinical and translational CAR-T research with high-dimensional data quality.

In vivo CAR-T Phenotypic Profiling

Memory CAR-T cells typically exhibit high proliferative capacity, rapid effector function, and long-term persistence.

Memory CAR-T Cell-Specific Markers. (Creative Biolabs Original)

Exhausted CAR-T cells are characterized by progressive loss of effector function, decreased proliferative capacity, sustained high expression of inhibitory receptors, and metabolic abnormalities.

Exhausted CAR-T Cell-Specific Markers. (Creative Biolabs Original)

Our Service Process

Required Starting Materials:

Live cell samples from in vivo sources.
Sample preservation: Fresh tissue in media or frozen cells in cryopreservation medium.
CAR information: CAR construct details (scFv source, detection tag, or anti-idiotype antibody availability) for CAR detection optimization.
Control samples: Matched non-transduced T cells or isotype controls for background definition.

Key Steps:

Workflow of multi-color flow cytometry for in vivo CAR-T phenotypic profiling: memory vs. exhaustion at Creative Biolabs. (Creative Biolabs Original)

Final Deliverables:

Raw Data Files.
Comprehensive Analysis Report.

Key Advantages

High-Dimensional Multiplexing: Our assay simultaneously detects ≥12 markers (surface, transcription factors, and functional molecules) within a single sample, eliminating segmentation errors for comprehensive memory versus exhaustion profiling.
Precise Functional Discrimination: It clearly delineates Memory-like from Exhausted CAR-T cells and identifies transitional states, capturing early signs of functional decline.
In vivo Microenvironment Preservation: By directly analyzing tumor-infiltrating or circulating CAR-T cells without ex vivo expansion, this method avoids artificial phenotypic shifts and preserves native metabolic and inhibitory receptor expression.
Quantitative Reproducibility: The service delivers multi-dimensional quantitative data supported by a standardized workflow including antibody titration and controls, ensuring batch-to-batch consistency.

FAQ

Q1: How is an individual cell suspension prepared from tumor tissue, and is assistance required from your team?

A1: We provide a standardized tissue dissociation protocol utilizing an enzyme cocktail combined with mechanical dissociation. Clients may send fresh or frozen tissue samples to us, and we will perform the complete workflow including dissociation, staining, and flow cytometry acquisition. Alternatively, we can supply a detailed protocol for clients who prefer to prepare the individual cell suspension themselves prior to sample submission.

Q2: How do you distinguish resting memory CAR-T cells from early activated CAR-T cells, given that both typically exhibit low PD-1 and low granzyme B expression?

A2: We utilize CD25 and CD69 as early activation markers to resolve this distinction. Resting memory CAR-T cells are characterized as CD25⁻CD69⁻ with high TCF-1 expression, whereas early activated cells are CD25⁺ and/or CD69⁺, with TCF-1 remaining positive but potentially showing low-level PD-1 upregulation. If required, we can incorporate CD25 and CD69 into our panel to enable this functional discrimination.

Why Choose Us?

We deliver high-dimensional, standardized flow cytometry panels that simultaneously resolve memory and exhaustion signatures in vivo. Our validated protocols, rigorous quality controls, and expert data interpretation ensure reproducible, clinically relevant profiling. Choose us to accurately assess CAR-T functional status and optimize therapeutic strategies with confidence.

Customer Reviews

"The standardized multi-color panel and rigorous quality controls allowed us to reproducibly track memory versus exhaustion kinetics across multiple mouse models. The inclusion of early activation markers (CD25, CD69) resolved the ambiguous 'low PD-1' populations that previously confounded our data. I highly recommend this service for any translational CAR-T study." Dr. James O'Brien.

"What impressed us most was the ability to simultaneously profile surface, transcription factor, and functional markers from a single tumor biopsy. The team provided clear gating strategies, controls, and a comprehensive report that correlated memory phenotype with in vivo persistence. This service has become an essential quality control step before our product release." Dr. Mei-Lin Chen.

How to contact us?

Reach out to our expert team today to discuss your specific CAR-T phenotyping needs. Whether you require a customized panel design, a detailed quote, or technical guidance, we are ready to assist. Simply complete the inquiry form on this page, and we will respond promptly to accelerate your research.

Reference

López-Cantillo, Gina et al. "CAR-T Cell Performance: How to Improve Their Persistence?." Frontiers in immunology vol. 13 878209. Distributed under Open Access License CC BY 4.0, without modification. https://doi.org/10.3389/fimmu.2022.878209.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.